Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Clinical and Radiological Profile and Response to Steroids
Open Access
- 7 December 2023
- journal article
- research article
- Published by Elsevier in Gastro Hep Advances
- Vol. 3 (3) , 361-367
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Picking a Zebra Among Horses: More Difficult Than You Think!Gastroenterology, 2022
- Autoimmune Pancreatitis Secondary to Immune Checkpoint Inhibitor Therapy (Type 3 AIP): Insights Into a New Disease From Serial Pancreatic ImagingGastroenterology, 2022
- Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)Current Opinion in Gastroenterology, 2022
- Chronic PancreatitisNew England Journal of Medicine, 2022
- Immune-related adverse events of checkpoint inhibitorsNature Reviews Disease Primers, 2020
- Cardiorenal complications of immune checkpoint inhibitorsNature Reviews Nephrology, 2018
- Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewEuropean Journal of Cancer, 2016
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2015
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Histopathologic and Clinical Subtypes of Autoimmune Pancreatitis: The Honolulu Consensus DocumentPancreatology, 2011